Bacterial infection and activation of the contact pathway of coagulation
Blood Vessels, Thrombosis & Hemostasis · 2025-11 · 2 (4) · 100091
DOI: 10.1016/j.bvth.2025.100091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2025-11. Verfasst von André L Lira und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Institute of Allergy and Infectious Diseases, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
The excessive inflammatory and prothrombotic response to a bacterial infection creates a life-threatening medical condition in sepsis. The transition from localized to systemic thrombin generation is a hallmark of disseminated intravascular coagulation (DIC), a severe prothrombotic disorder resulting in microvascular thrombosis and subsequent multiorgan failure. The contact pathway of coagulation has been shown to play roles both in the initiation and amplification of thrombin generation in models of sepsis. The contact pathway consists of the coagulation factors XII (FXII) and XI (FXI), prekallikrein, and high- molecular-weight kininogen. Activation of the contact pathway can be triggered by binding to anionic surfaces, such as the ionized phosphoryl and carboxylate groups present on bacterial surface macromolecules. In particular, FXII has been shown to bind to the components of the bacterial envelope, including adhesins, peptidoglycan, lipopolysaccharides from gram-negative bacteria, and lipoteichoic acids from gram-positive bacteria. This review discusses the molecular pathways linking activation of the contact pathway by the envelope structures of bacterial and downstream thrombin generation and inflammation associated with sepsis-induced coagulopathies. We highlight the potential for FXII and FXI as potential therapeutic options for safely preventing DIC in sepsis.
Autor:innen und Institutionen
- Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.
- Division of Hematology and Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR.
- Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
- Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
- Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
- Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Förderung
- NHLBI NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Heart, Lung, and Blood Institute
Zitieren
APA
Lira, A. L., Puy, C., Shatzel, J. J., Lupu, F., & McCarty, O. J. T. (2025). Bacterial infection and activation of the contact pathway of coagulation. Blood Vessels, Thrombosis & Hemostasis, 2(4), 100091. https://doi.org/10.1016/j.bvth.2025.100091
Vancouver
Lira AL, Puy C, Shatzel JJ, Lupu F, McCarty OJT. Bacterial infection and activation of the contact pathway of coagulation. Blood Vessels, Thrombosis & Hemostasis. 2025;2(4):100091. doi:10.1016/j.bvth.2025.100091
BibTeX
@article{Lira2025,
author = {Lira, André L and Puy, Cristina and Shatzel, Joseph J and Lupu, Florea and McCarty, Owen J T},
title = {Bacterial infection and activation of the contact pathway of coagulation},
journal = {Blood Vessels, Thrombosis & Hemostasis},
year = {2025},
volume = {2},
number = {4},
pages = {100091},
doi = {10.1016/j.bvth.2025.100091}
}
EUVIMED